Compare Imperial Oil Limited Common Stock (IMO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Imperial Oil Limited Common Stock vs Medpace Holdings Inc — how do they compare? Imperial Oil Limited Common Stock trades at $130.2 (market cap $62.22B), while Medpace Holdings Inc trades at $616.98 (market cap $17.02B). The key difference: Imperial Oil Limited Common Stock is far larger — about 3.7× Medpace Holdings Inc's market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| IMO | MEDP | |
|---|---|---|
Market Cap | $62.22B | $17.02B |
Volume | 560,544 | 155,250 |
Sector | Energy | Health |
52-Week High | $138.33 | $630.19 |
52-Week Low | $83.72 | $393.42 |
Enterprise Value | $63.13B | $16.63B |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MEDP trades at $609.89, down 1.64% with a bullish technical outlook. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent news highlights CEO stock sales and institutional position adjustments, while Q3 2026 results are expected October 21, 2026.
MEDP offers growth potential with a consensus price target of $620.44 (1.7% upside), supported by projected 2026 revenue growth to $2.8B. Risks include high valuation multiples (P/E 35.82) and insider selling. Analyst sentiment is cautious with 78.95% hold ratings, suggesting limited near-term catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Imperial Oil Limited Common Stock
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
